
Readers discuss the pharmacist's role in OTC selection, voice appreciation for Stan Illich's views, argue that pharmacists need to realize who's in the driver's seat, and share their appreciation for JP.

Readers discuss the pharmacist's role in OTC selection, voice appreciation for Stan Illich's views, argue that pharmacists need to realize who's in the driver's seat, and share their appreciation for JP.

FDA approves Prepopik and a new indication for Truvada.

You leave the day job and what happens? The most fulfilling moments a pharmacist can have occur when you're nowhere near a pharmacy.

A survey of new Rx, new generic, and new OTC products

Treatment with omega-3 polyunsaturated fatty acids to prevent cardiovascular disease has been controversial.

Patients taking long-term warfarin who had bleeding from their gastrointestinal tract should resume warfarin once the bleeding episode is under control, to reduce their risk of thrombosis.

A bedside medication verification system at Cook Children's Medical Center (CCMC) in Fort Worth, Texas, has resulted in a 97% rate of compliance with electronic scanning of medications and patients.

Trying to save on Rx drugs from the secondary market can land you in hot water with Uncle Sam.

Screening patients who are at high risk for diabetes does not reduce their all-cause, cardiovascular, or diabetes-related mortality within 10 years, according to a study published Oct. 4 in The Lancet

Women who take HRT for 10 years following menopause have a significantly reduced risk of mortality, heart failure, and heart attack without any increased risk of cancer, DVT, or stroke, a Danish study published on bmj.com showed.

New evidence suggests that statins generate large survival and health benefits at the population level and greater use of and adherence to statins should be encouraged, according to a study published in the October issue of Health Affairs.

The Agency for Healthcare Research and Quality (AHRQ) is trying to help strengthen the medication reconciliation process with the use of a new toolkit.

Perioperative dexamethasone administered during tonsillectomy in children is not associated with excessive bleeding events, according to a study published in the Sept. 26 issue of JAMA.

The best method to prevent unintended pregnancy in teenage girls is the use of intrauterine devices and contraceptive implants, according to the latest guidelines issued by the American College of Obstetricians and Gynecologists.

Tranexamic acid can safely be used in all trauma patients, not just those who are the most severely injured, according to data analyses results published in the Sept. 11 issue of the British Medical Journal.

A group of 45 pharmacies in southern Texas are doing their best to get their patients registered, and ready to vote Nov. 6 in the hopes that the state will pay more attention to the struggling pharmacies in the four-county area.

As the number of cases and deaths associated with the national meningitis outbreak continues to rise, one has to ask the question, could this public health disaster been averted?

The National Association of Specialty Pharmacy (NASP), a new organization that focuses on specialty pharmacy, had its first event this week at the Academy of Managed Care Pharmacy Educational Conference in Cincinnati, Ohio, and it announced Michael A. Nameth, RPh, MBA, will serve as the interim executive director.

The U.S. Pharmacopeial Convention (USP) is in the process of changing the look and format of prescription labels to make them easier for patients to understand.

After reviewing new data, FDA has concluded that Budeprion XL 300 mg (bupropion hydrochloride extended-release tablets), manufactured by Impax Laboratories, Inc., and marketed by Teva Pharmaceuticals USA, Inc., is not therapeutically equivalent to GlaxoSmithKline’s Wellbutrin XL 300 mg.

An Illinois appeals court recently upheld a ruling that pharmacists are permitted to refrain from prescribing emergency contraceptives, finding that healthcare professionals are protected by an Illinois state law.

FDA has approved Boston Therapeutic’s petition to file an Abbreviated New Drug Application (ANDA) for a new, chewable tablet formulation of the diabetes drug metformin hydrochloride. The company plans to market the new formulation under the name Pazamet.

Metformin is a safe and effective drug for the treatment of type 2 diabetes and can be used in patients with varying degrees of renal impairment, according to a long-term observational study that was published online in the British Medical Journal.

Most adults – 71% – believe it's important to be up-to-date on immunizations to be healthy, but that isn't reflected in the number of adults who actually get vaccinated, according to a new Walgreens Immunization Index study.

The Centers for Disease Control and Prevention (CDC) and the FDA are jointly investigating a meningitis outbreak that has affected approximately 35 people in six states so far. Five patients have died and 30 are ill after receiving an epidural steroid injection contaminated by fungus, according to a report issued from CDC yesterday.

Abbott Laboratories Inc. was sentenced Oct. 2 to pay a total of $700 million after pleading guilty in May to misbranding divalproex (Depakote), a criminal misdemeanor.

Biologic response modifiers developed for the treatment of rheumatoid arthritis do not appear to be associated with an increased risk of cancer, according to a study published September 5 in the Journal of the American Medical Association.

Children with asthma who use glucocorticoid inhalers may grow shorter on average than those who do not use inhaled corticosteroids (ICS), according to a study published September 6 in the New England Journal of Medicine.

FDA has granted delafloxacin (Rib-X) as a Qualified Infectious Disease Product (QIDP) for the indications of acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP).

While beta-blocker use continues to be the standard of care for patients with coronary artery disease (CAD), especially for those patients who have had a myocardial infarction (MI), these drugs may not be effective long term, according to an online report published Oct. 3 in JAMA.